Status:
COMPLETED
Chalazion Conservative Treatment Trial
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Icahn School of Medicine at Mount Sinai
Edward-Elmhurst Health System
Conditions:
Chalazion Unspecified Eye, Unspecified Eyelid
Chalazion Left Eye, Unspecified Eyelid
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, s...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients age 18 and above
- Patient with a palpable chalazion on any eyelid
- Patients with multiple chalazia but only a single one on each lid
- Normal lid anatomy enabling lid eversion
- Exclusion Criteria
- Patients with chalazia with atypical features (recurring chalazion, abnormal surrounding lid tissue, associated loss of lashes) that may indicate suspicion of malignancy
- Patients allergic to any agents being used in the study (tobramycin, dexamethasone)
- Patients who have had previous eyelid surgery to the same eyelid as the chalazion
- Patients under 18 years of age
- Patients without palpable lid chalazion
- Patients with multiple chalazia on one eyelid
- Patients with concurrent eyelid infection (cellulitis or conjunctivitis)
- Patients unable to give consent
Exclusion
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01230593
Start Date
November 1 2010
End Date
March 1 2016
Last Update
June 12 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Elmhurst Hospital Center
Elmhurst, New York, United States, 11373
2
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
3
St. Joseph's Hospital Eye Clinic
Stoney Creek, Ontario, Canada, L8G 5E4